Mougin B - Search Results

1

High-risk genotype for type 1 diabetes: a new simple microtiter plate-based ELOSA assay.

Geranton S, Rostagnat-Stefanutti A, Bendelac N, Cerrato E, Barbalat V, Leissner P, Nicolino M, Thivolet C, Mougin B. Geranton S, et al. Among authors: mougin b. Genet Test. 2003 Spring;7(1):7-12. doi: 10.1089/109065703321560877. Genet Test. 2003. PMID: 12820696

2

Lack of association of IL-10 promoter gene variants with type 1 diabetes in a French population.

Reynier F, Cazalis MA, Lecoq A, Paye M, Rosa A, Durand A, Jhumka U, Mougin B, Miossec P, Bendelac N, Nicolino M, Thivolet C. Reynier F, et al. Among authors: mougin b. Hum Immunol. 2006 Apr-May;67(4-5):311-7. doi: 10.1016/j.humimm.2006.02.029. Epub 2006 Apr 7. Hum Immunol. 2006. PMID: 16720211

3

Specific gene expression signature associated with development of autoimmune type-I diabetes using whole-blood microarray analysis.

Reynier F, Pachot A, Paye M, Xu Q, Turrel-Davin F, Petit F, Hot A, Auffray C, Bendelac N, Nicolino M, Mougin B, Thivolet C. Reynier F, et al. Among authors: mougin b. Genes Immun. 2010 Apr;11(3):269-78. doi: 10.1038/gene.2009.112. Epub 2010 Jan 21. Genes Immun. 2010. PMID: 20090770

4

A routine assay for the direct analysis of HLA-DR-related shared epitope and B27 alleles in chronic inflammatory arthritis.

Mougin B, Garnero P, Borel O, Compagnon C, Barbalat V, Marotte H, Miossec P. Mougin B, et al. J Immunol Methods. 2001 Oct 1;256(1-2):47-53. doi: 10.1016/s0022-1759(01)00441-0. J Immunol Methods. 2001. PMID: 11516754

5

A rapid semi automated method for DNA extraction from dried-blood spots: application to the HLA-DR shared epitope analysis in rheumatoid arthritis.

Pachot A, Barbalat V, Marotte H, Diasparra J, Gouraud A, Mougin B, Miossec P. Pachot A, et al. Among authors: mougin b. J Immunol Methods. 2007 Dec 1;328(1-2):220-5. doi: 10.1016/j.jim.2007.08.001. Epub 2007 Sep 4. J Immunol Methods. 2007. PMID: 17884081

6

DNA nucleic acid sequence-based amplification-based genotyping for polymorphism analysis.

Berard C, Cazalis MA, Leissner P, Mougin B. Berard C, et al. Among authors: mougin b. Biotechniques. 2004 Oct;37(4):680-2, 684, 686. doi: 10.2144/04374DD04. Biotechniques. 2004. PMID: 15517981 Free article.

7

Multiparametric duplex real-time nucleic acid sequence-based amplification assay for mRNA profiling.

Verjat T, Cerrato E, Jacobs M, Leissner P, Mougin B. Verjat T, et al. Among authors: mougin b. Biotechniques. 2004 Sep;37(3):476-81. doi: 10.2144/04373PF01. Biotechniques. 2004. PMID: 15470903 Free article.

8

Urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 mRNA assessment in breast cancer by means of NASBA: correlation with protein expression.

Lamy PJ, Verjat T, Servanton AC, Paye M, Leissner P, Mougin B. Lamy PJ, et al. Among authors: mougin b. Am J Clin Pathol. 2007 Sep;128(3):404-13. doi: 10.1309/K4JAF2NMD5EJU67Y. Am J Clin Pathol. 2007. PMID: 17709314

9

Prognostic significance of urokinase plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancer.

Leissner P, Verjat T, Bachelot T, Paye M, Krause A, Puisieux A, Mougin B. Leissner P, et al. Among authors: mougin b. BMC Cancer. 2006 Aug 31;6:216. doi: 10.1186/1471-2407-6-216. BMC Cancer. 2006. PMID: 16945123 Free PMC article.

10

NASBA: a novel approach to assess hormonal receptors and ERBB2 status in breast cancer.

Lamy PJ, Verjat T, Paye M, Servanton AC, Grenier J, Leissner P, Mougin B. Lamy PJ, et al. Among authors: mougin b. Clin Chem Lab Med. 2006;44(1):3-12. doi: 10.1515/CCLM.2006.002. Clin Chem Lab Med. 2006. PMID: 16375577

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters